FDA Approved: VIVITROL — Supplemental Application (Alkermes, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for VIVITROL (naltrexone) submitted by Alkermes, potentially expanding its labeling or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Opioid Use Disorder

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

SUPPL AP for VIVITROL (NALTREXONE)